Hospital heart failure registry for adults in Santiago
Part of Heart & circulation clinical trials.
This is a registry study that collects information from adults hospitalized for heart failure in Santiago. It aims to better understand heart failure in real-world patients, including differences by sex, by tracking what happens during the hospital stay.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You can sign an informed consent form (or your legal representative can)
- You are being admitted to the hospital for heart failure
- Your doctors plan to start or continue heart-related treatment during this hospital stay
- You do not have an active severe COVID-19 infection or confirmed severe COVID pneumonia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from adults admitted to hospitals in Brazil with either a recent heart attack that weakened the heart or with worsening heart failure. The goal is to learn more about these conditions to improve care.
This is a hospital-based study that collects standardized information about adults with specific heart conditions—heart failure, coronary artery disease, or atrial fibrillation. It may help doctors and researchers better understand these diseases and improve future care.
This study creates a registry of people with chronic heart failure to track their health over time. It may help researchers learn more about the condition and improve future care.
This trial studies how to better assess and manage risk in people hospitalized with heart failure or related serious heart problems. It may help by improving how clinicians monitor your condition over time and decide next steps.
This study is creating a registry to track and learn from people with advanced heart failure or who have had a heart transplant. By joining, you help researchers better understand these conditions and improve care.
This study registers people who are referred to cardiology or genetics for heart-failure–type symptoms or heart/cardiogenetic screening. It helps doctors understand how monitoring platforms may support diagnosis and follow-up.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.